Commercialization: Page 65

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Social Media

    Social Media Trends, Regs, and Apps Featured Briefs: Nontraditional Players Get Into the Healthcare Game IBM’s Watson: “Alex, I’ll Take Medicine for $500 Please" Facebook Made Easier for Brands Apps… Amazon Enters Medical App ­Market Have a Great Idea for an App? Tweets… First Patient-to-Physicia...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: New System Uses Cloud to Streamline Content Management R&D Architecture Seeks to Speed Scientific Innovation In other technology news… E-UPGRADES AND ENHANCEMENTS Veeva Vault, a cloud-based, regulated content ...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Featured Briefs: New Company Stakes Out Contract Diagnostics Category TGaS Advisors Expands ­Offerings in Managed Markets, Marketing In other news… ON THE SHELVES Trend: Recent growth in biomarker research is creating a need for clinical te...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: R&D Productivity Measures Consistently Undervalued Generics Firms Turning to M&A for Market Foothold Sidebar: Top 10 New Product Approvals in 2010 Specialty, Hospital Sales Forces Anticipate Double-Digit Growth P...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Showcase Feature — IRBs Watching the Protectors

    Ever-changing clinical-trial regulations and continued growth in multicenter and international studies have resulted in an exponential increase in the volume of data generated for IRB review, including large numbers of individual adverse event (AE) reports, which often lack the context and detail...

    By Carolyn Gretton • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Skill, Science, and the Art of the Conversation

    Shifting marketplace dynamics have created unprecedented challenges for pharma industry sales organizations. Increasing hurdles to physician access, governmental and industry constraints on promotion, competition from generics, and diminishing degrees of differentiation among products have combin...

    By Jennifer Munsie • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Focus on Specialty Reps: From Information Source to Information Connector

    TGaS Advisors Training & Development Practice There is a jump in demand for data on specialty sales areas, including oncology, biopharma, and niche therapy markets. As primary care recedes in relative importance in many — though not all — companies, large-tier companies are focusing more on h...

    By Chris Goins • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    From KOL to COL: Regional Influencers are Critical to Commercial Model Re-invention

    The commercial model in pharmaceutical sales is under dramatic pressure that necessitates a radical shift in how drug companies interact with key customers. Primarily, marketers must explore more effective conduits for accessing physicians who have organized into ever more complex networks and no...

    By Kelly Myers • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    KOL Mapping: The GPS of Thought Leader Identification

    Mapping charts the quickest route to finding the right KOLs. With all of today’s technology-driven data capture capabilities, there is a lot of thought leader information to be garnered, but all that knowledge is only as good as its relevance. KOL mapping serves as a guiding tool that cuts throug...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Minding the As & Qs of Lead Gen Technology

    Augmented reality (AR) may sound new, but actually it has been around for at least 10 years, reports say, and it is the recent uptake in smartphone use and capability, along with funding from the Recovery Act, that have pushed AR to the front and center of pharma marketing plans. Using a smartpho...

    By Robin Robinson • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Uncovering the Value of Late-Phase Trials

    Finding Added Value in Late-Phase Research Postapproval studies are becoming bigger and more expensive. As a result, ­pharmaceutical ­sponsors are looking at other ways to use the data generated from these studies to create value for their organizations. Postmarketing studies are becoming increas...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    PV: What are some ways pharmaceutical ­companies can use social media to reach patients? Gupta: The key benefit for pharmaceutical companies is to better understand the patient’s perspective. For many illnesses, especially chronic diseases, patients face many issues beyond the actual medication, ...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Social Media

    In January, Sanofi-Aventis surprised the industry by launching the first ever pharma blog — Discuss Diabetes — that encourages a two-way communication with diabetes patients. According to Laura Kolodjeski, senior manager, U.S. Diabetes Patient Solutions and blog curator, sanofi-aventis views soci...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Tufts Institute Seeks to Increase Biopharma Partnerships Contracting Module Reduces Study Cycle Time In other technology news… E-UPGRADES AND ENHANCEMENTS The Tufts Institute for ­Biomedical Partnerships is a glob...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Pharma Faces Record Patent Expirations Sidebars: Projected U.S. sales of top products going off patent in 2011 Projected U.S. sales of top products going off patent in 2012 New Product Planning Team Key to Launch Success...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Ready to Take a Risk Again?

    As agencies, we share a responsibility to experiment and push boundaries to drive our brands’ — and our Clients — success. Media channels and offerings are varied and increasing every day. The potential for innovation within the digital media sphere is such that you can create what you need versu...

    By Tatiana Lyons SVP • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What Advances in Technology did to Healthcare Communications

    Welcome to the 21st century — a time period where advances in electronic media have opened new opportunities to communicate with physicians and patients, explore ­creativity, and help bring the health care world closer together. But as we’ll see, there are some things in our business that even th...

    By Barclay Missen • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Reach More Potential Patients

    In the year ending October 2010, more than $4.4 billion was spent to promote drugs directly to consumers (DTC) through television, magazine, newspaper, Internet, radio, and outdoor advertisements. Although spending was higher when there were more blockbusters being advertised, there are still man...

    By Melissa Leonhauser Director • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    202020 VISION

    Ogilvy CommonHealth Worldwide, part of the Ogilvy & Mather network and a WPP company, represents the largest assembly of creative talent in the world of healthcare communications with 64 offices across 36 countries. { For more information visit ogilvychww.com. To request the full version of t...

    By David Davenport-Firth • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Pharma Advertising: The 3.0 Version

    According to Ernst & Young’s Progressions 2011 report, in the world of Pharma 3.0, success will be based not on how many drug units are sold, but on how well pharma’s market offerings improve health outcomes, putting patients and payers at the center of the model. As part of this transition, ...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Namaste India: Growth Across the Board

    India’s importance in the pharmaceutical space is indisputable. With healthcare booming, a strong medical infrastructure, lower costs, and high levels of patient recruitment and retention, India presents enormous potential. The pharmaceutical business has been growing by 12% to 13% over the past ...

    By Kim Ribbink • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Thought Leaders

    Ryan Abbate. President, Pacific ­Communications, a healthcare communications agency that ­offers strategic and tactical communications solutions. For more information, visit ­ ­pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ­Medicine Coalition, which brings together the academ...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Technology at the Speed of Light

    The impact that the Internet and follow-on technologies have had on all areas of the life-sciences is well-documented throughout this special section, and the majority of our thought leaders have identified this as the biggest game changer in the last 10 years. Going even further, these same thou...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The End of the Arms Race

    After more than a decade of crowding physicians’ offices with as many sales reps who would fit, the pendulum has swung ­dramatically in the other direction. The industry’s field ranks have been reduced dramatically, and now sales reps are crowding unemployment offices. Not just a Hired Gun Terren...

    By PharmaVoice Team • March 7, 2011